Markussen Lisa Torsdatter, Kivelä Jemina, Lindström Jaana, Ollikainen Miina, Kytö Mikko, Heinonen Seppo, Koivusalo Saila, Meinilä Jelena
Department of Food and Nutrition, University of Helsinki, Helsinki, Finland.
Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Tukholmankatu 8, Biomedicum 2C, 00029 HUS, Helsinki, Finland.
BMC Nutr. 2025 Jan 16;11(1):12. doi: 10.1186/s40795-024-00988-x.
Gestational Diabetes Mellitus (GDM) prevalence is rising worldwide, but optimal dietary strategies remain unclear. The eMOM pilot RCT compared a plant-protein rich Healthy Nordic Diet (HND) and a moderately carbohydrate restricted diet (MCRD) and their potential effects on time in glucose target range (≤ 7.8 mmol/L, %TIR), and on newborn body composition.
Forty-two participants were randomized to either HND (n = 20) or MCRD (n = 22) face-to-face nutritional counseling from gestational weeks (GW) 24 + 0-28 + 6 (baseline) until delivery. The HND intervention had no restriction in carbohydrate intake and emphasized plant-based protein sources and Nordic food, while the MCRD had a moderate carbohydrate restriction (~ 40% in proportion to total daily energy consumption, E%). Continuous glucose monitoring was worn for 14 days to assess glucose levels and %TIR. Blood samples for glucose and lipid metabolism and 3-day food diaries were collected at baseline and at GW 34 + 0-35 + 6. Neonatal body composition was measured by air displacement plethysmography. Difference between groups were analysed with t-test and Wilcoxon test.
Thirty-two women completed the study. Both groups maintained the %TIR during majority of the time (98.9 and 99.3% for MCRD and HND respectively, p = 0.921) in GW 34 + 0 - 35 + 6. The mean glucose was lower in the MCRD group compared to the HND group (5.0 SD 1.03 vs. 5.2 SD 0.96 mmol/l, p < 0.001). No differences were observed in glucose variability, lipid metabolism, gestational weight gain, or in the body composition of the newborns. HND had lower diet macronutrient adherence than the MCRD, resulting in similar macronutrient composition in both groups. The mean macronutrient intakes were fat: 40.6 vs. 39.5 E%, carbohydrate: 40.5 vs. 42.4 E%, protein: 18.9 vs. 18.1 E% for the MCRD and HND groups, respectively. The HND decreased intake of meat and increased fish consumption significantly compared to the MCRD.
Both a moderately restricted carbohydrate diet and a diet focused on plant-based protein effectively maintained a large time within the treatment target range in women with GDM. Further research could explore the impact of protein quantity and sources in maternal diets on glycemic control and newborn outcomes.
The eMOM pilot trial is registered in Clinicaltrials.gov (21/09/2018, NCT03681054).
妊娠期糖尿病(GDM)在全球范围内的患病率正在上升,但最佳饮食策略仍不明确。eMOM试点随机对照试验比较了富含植物蛋白的健康北欧饮食(HND)和适度限制碳水化合物的饮食(MCRD)及其对血糖目标范围内时间(≤7.8 mmol/L,%TIR)和新生儿身体成分的潜在影响。
42名参与者在妊娠周数(GW)24 + 0至28 + 6(基线)直至分娩期间被随机分为HND组(n = 20)或MCRD组(n = 22),接受面对面的营养咨询。HND干预对碳水化合物摄入量没有限制,强调植物性蛋白质来源和北欧食物,而MCRD则适度限制碳水化合物(占每日总能量消耗的比例约为40%,E%)。连续佩戴14天的葡萄糖监测仪以评估血糖水平和%TIR。在基线和GW 34 + 0至35 + 6时采集血糖和脂质代谢的血样以及3天的食物日记。通过空气置换体积描记法测量新生儿身体成分。使用t检验和Wilcoxon检验分析组间差异。
32名女性完成了研究。在GW 34 + 0至35 + 6期间,两组在大部分时间内都维持了%TIR(MCRD组和HND组分别为98.9%和99.3%,p = 0.921)。MCRD组的平均血糖低于HND组(5.0 SD 1.03 vs. 5.2 SD 0.96 mmol/l,p < 0.001)。在血糖变异性、脂质代谢、孕期体重增加或新生儿身体成分方面未观察到差异。HND的饮食宏量营养素依从性低于MCRD,导致两组的宏量营养素组成相似。MCRD组和HND组的平均宏量营养素摄入量分别为:脂肪:40.6 vs. 39.5 E%,碳水化合物:40.5 vs. 42.4 E%,蛋白质:18.9 vs. 18.1 E%。与MCRD相比,HND显著减少了肉类摄入量并增加了鱼类消费量。
适度限制碳水化合物的饮食和以植物性蛋白质为重点的饮食都能有效地使GDM女性在治疗目标范围内保持较长时间。进一步的研究可以探索母体饮食中蛋白质的数量和来源对血糖控制和新生儿结局的影响。
eMOM试点试验已在Clinicaltrials.gov注册(2018年9月21日,NCT03681054)。